{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:51:18Z","timestamp":1789429878398,"version":"build-2803163510"},"reference-count":54,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1513,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1111\/j.1365-2710.2011.01284.x","type":"journal-article","created":{"date-parts":[[2011,7,11]],"date-time":"2011-07-11T07:38:24Z","timestamp":1310369904000},"page":"260-265","source":"Crossref","is-referenced-by-count":19,"title":["CB1-independent mechanisms of \u03949-THCV, AM251 and SR141716 (rimonabant)"],"prefix":"10.1155","volume":"37","author":[{"given":"R. B.","family":"Raffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,11]]},"reference":[{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2710.2007.00817.x","article-title":"The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism - or inverse agonism - as potential obesity treatment and other therapeutic use","volume":"32","author":"Xie","year":"2007","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ijo.2009.132","article-title":"Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions","volume":"33","author":"Fong","year":"2009","journal-title":"International Journal of Obesity"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/14728210902736568","article-title":"Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis","volume":"14","author":"Janero","year":"2009","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MOL.0b013e328304b62b","article-title":"Endocannabinoid system in food intake and metabolic regulation","volume":"19","author":"Jesudason","year":"2008","journal-title":"Current Opinion in Lipidology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.physbeh.2007.11.007","article-title":"Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties","volume":"93","author":"Bergman","year":"2008","journal-title":"Physiology and Behavior"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2174\/092986706778201512","article-title":"Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation","volume":"13","author":"Tucci","year":"2006","journal-title":"Current Medicinal Chemistry"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1359-6446(05)03427-6","article-title":"Keynote review: medicinal chemistry strategies to CB1 cannabinoid receptor antagonists","volume":"10","author":"Lange","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1389450053174514","article-title":"Cannabinoids and the regulation of ingestive behaviour","volume":"6","author":"Vickers","year":"2005","journal-title":"Current Drug Targets"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0024-3205(99)00285-4","article-title":"Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528","volume":"65","author":"Shire","year":"1999","journal-title":"Life Sciences"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008877-200509000-00010","article-title":"The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)","volume":"16","author":"Ward","year":"2005","journal-title":"Behavioural Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/sj.npp.1301384","article-title":"Effect of cannabinoid CB1 receptor antagonist SR141716A and CB1 receptor knockout on cue-induced reinstatement of Ensure and corn-oil seeking in mice","volume":"32","author":"Ward","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Molecular Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1074\/jbc.270.8.3726","article-title":"An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing","volume":"270","author":"Shire","year":"1995","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0022-3565(25)38654-4","article-title":"Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids","volume":"268","author":"Lynn","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"Pt 1","key":"10.1111\/j.1365-2710.2011.01284.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2790129","article-title":"Molecular cloning of a human cannabinoid receptor which is also expressed in testis","volume":"279","author":"Gerard","year":"1991","journal-title":"Biochemical Journal"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0026-895X(25)12377-8","article-title":"Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes","volume":"27","author":"Howlett","year":"1985","journal-title":"Molecular Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/nbdi.1998.0229","article-title":"The functional neuroanatomy of brain cannabinoid receptors","volume":"5","author":"Breivogel","year":"1998","journal-title":"Neurobiology of Disease"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(98)00075-1","article-title":"Cannabis and endogenous cannabinoid systems","volume":"51","author":"Childers","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3565(25)38122-X","article-title":"Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities","volume":"265","author":"Compton","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-3565(25)12911-X","article-title":"In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity","volume":"277","author":"Compton","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/bjp.2008.190","article-title":"Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes","volume":"154","author":"Dennis","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB25|cit25","first-page":"48","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"British Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0024-3205(79)90505-8","article-title":"pA2 and receptor differentiation: a statistical analysis of competitive antagonism","volume":"25","author":"Tallarida","year":"1979","journal-title":"Life Sciences"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","article-title":"Inverse agonism and neutral antagonism at cannabinoid CB1 receptors","volume":"76","author":"Pertwee","year":"2005","journal-title":"Life Sciences"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","article-title":"Evidence for a new G protein-coupled cannabinoid receptor in mouse brain","volume":"60","author":"Breivogel","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/jpet.109.152710","article-title":"CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells","volume":"330","author":"Cinar","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2010.10.085","article-title":"Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist","volume":"651","author":"Wiley","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2004.05.015","article-title":"Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens","volume":"127","author":"Pickel","year":"2004","journal-title":"Neuroscience"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annual Reviews of Biochemistry"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1074\/jbc.M710300200","article-title":"Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors","volume":"283","author":"Canals","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0024-3205(91)90154-4","article-title":"Opioid receptor-coupled second messenger systems","volume":"48","author":"Childers","year":"1991","journal-title":"Life Sciences"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/jpet.104.066837","article-title":"Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling","volume":"310","author":"Sz\u00fccs","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.molbrainres.2004.12.016","article-title":"Biochemical demonstration of mu-opioid receptor association with Gsalpha: enhancement following morphine exposure","volume":"135","author":"Chakrabarti","year":"2005","journal-title":"Brain Research (Molecular Brain Research)"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.euroneuro.2009.11.002","article-title":"Potential anxiogenic effects of cannabinoid CB1 receptor antagonists\/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142","volume":"20","author":"Sink","year":"2010","journal-title":"European Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0022-3565(25)20674-7","article-title":"Characterization of two cloned human CB1 cannabinoid receptor isoforms","volume":"278","author":"Rinaldi-Carmona","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions","volume":"138","author":"Tzavara","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2174\/092986710790980050","article-title":"Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists","volume":"17","author":"Pertwee","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/j.1460-9568.2009.06750.x","article-title":"Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716)","volume":"29","author":"Verty","year":"2009","journal-title":"European Journal of Neuroscience"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/187152706777452263","article-title":"G protein-coupled receptors in regulation of body weight","volume":"5","author":"Schi\u00f6th","year":"2006","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"23731","DOI":"10.1074\/jbc.M212369200","article-title":"Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716","volume":"278","author":"Hilairet","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2007.05.027","article-title":"Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1","volume":"54","author":"Crespo","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(01)00784-1","article-title":"Inhibitory effects of SR141716A on G-protein activation in rat brain","volume":"414","author":"Sim-Selley","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.bjp.0705577","article-title":"An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors","volume":"140","author":"Savinainen","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.neuron.2007.12.027","article-title":"TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons","volume":"57","author":"Gibson","year":"2008","journal-title":"Neuron"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/FBP.0b013e328331ba30","article-title":"Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice","volume":"20","author":"Ward","year":"2009","journal-title":"Behavioural Pharmacology"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"European Journal of Neuroscience"},{"key":"10.1111\/j.1365-2710.2011.01284.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(03)01295-0","article-title":"Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a \u201cCB3\u201d receptor","volume":"461","author":"Fride","year":"2003","journal-title":"European Journal of Pharmacology"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2011.01284.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2011.01284.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:27:31Z","timestamp":1741310851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2011.01284.x"}},"subtitle":["CB1-independent mechanisms"],"short-title":[],"issued":{"date-parts":[[2011,7,11]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2011.01284.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,11]]}}}